Although the frustrations surrounding training facilities may be ebbing, the N.C.A.A. also faced criticism for its decision to use rapid antigen tests at the women’s tournament, not the polymerase chain reaction tests that are in use at the men’s tournament and are considered the gold standard of infectious disease diagnostics.
On Friday, Mark Emmert, the N.C.A.A. president, said the association had “complete confidence in all the medical protocols that have been put together.”
Article source: https://www.nytimes.com/2021/03/20/sports/ncaabasketball/ncaa-tournament-women-weight-room.html